Clinical trials: Hypertrophy, Left Ventricular

Hypertrophic Cardiomyopathy

Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem

• Completed
• Age: 5 to 39 years
• Phase 2/3
• Results posted

This is a pilot clinical trial to assess whether the administration of diltiazem may be able to decrease the development or progression of hypertrophic cardiomyopathy (HCM).

Trial name

NCT00319982

Testing

Diltiazem

Where

2 sites in United States

Volunteers

39 people

Sponsor

Brigham and Women's Hospital